Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Orthopedics Research Institute of Zhejiang University, Hangzhou, Zhejiang, China.
Mol Cancer. 2024 Sep 9;23(1):193. doi: 10.1186/s12943-024-02104-w.
CD8 T cells are the workhorses executing adaptive anti-tumour response, and targets of various cancer immunotherapies. Latest advances have unearthed the sheer heterogeneity of CD8 tumour infiltrating lymphocytes, and made it increasingly clear that the bulk of the endogenous and therapeutically induced tumour-suppressive momentum hinges on a particular selection of CD8 T cells with advantageous attributes, namely the memory and stem-like exhausted subsets. A scrutiny of the contemporary perception of CD8 T cells in cancer and the subgroups of interest along with the factors arbitrating their infiltration contextures, presented herein, may serve as the groundwork for future endeavours to probe further into the regulatory networks underlying their differentiation and migration, and optimise T cell-based immunotherapies accordingly.
CD8 T 细胞是执行适应性抗肿瘤反应的主力军,也是各种癌症免疫疗法的靶点。最新的进展揭示了 CD8 肿瘤浸润淋巴细胞的巨大异质性,并越来越清楚的表明,内源性和治疗性诱导的肿瘤抑制动力主要取决于具有有利特性的特定选择的 CD8 T 细胞,即记忆和类干细胞衰竭亚群。本文对当前癌症中 CD8 T 细胞及其相关亚群的认知以及决定其浸润结构的因素进行了审查,可为进一步探究其分化和迁移的调控网络以及相应地优化基于 T 细胞的免疫疗法奠定基础。